瑞典 - 瑞典文 - Läkemedelsverket (Medical Products Agency)

aurobindo pharma (malta) limited - bosentanmonohydrat - filmdragerad tablett - 62,5 mg - bosentanmonohydrat 64,541 mg aktiv substans - bosentan

瑞典 - 瑞典文 - Läkemedelsverket (Medical Products Agency)

ferrer internacional, sa. - treprostinil - infusionsvätska, lösning - 1 mg/ml - treprostinil 1 mg aktiv substans - treprostinil

瑞典 - 瑞典文 - Läkemedelsverket (Medical Products Agency)

orifarm ab - treprostinil - infusionsvätska, lösning - 1 mg/ml - treprostinil 1 mg aktiv substans - treprostinil

瑞典 - 瑞典文 - Läkemedelsverket (Medical Products Agency)

ferrer internacional, sa. - treprostinil - infusionsvätska, lösning - 10 mg/ml - treprostinil 10 mg aktiv substans - treprostinil

瑞典 - 瑞典文 - Läkemedelsverket (Medical Products Agency)

ferrer internacional, sa. - treprostinil - infusionsvätska, lösning - 2,5 mg/ml - treprostinil 2,5 mg aktiv substans - treprostinil

瑞典 - 瑞典文 - Läkemedelsverket (Medical Products Agency)

ferrer internacional, sa. - treprostinil - infusionsvätska, lösning - 5 mg/ml - treprostinil 5 mg aktiv substans - treprostinil

欧盟 - 瑞典文 - EMA (European Medicines Agency)

bayer ag - riociguat - hypertoni, lungformig - antihypertensiva medel mot pulmonell arteriell hypertension - chronic thromboembolic pulmonary hypertension (cteph)adempas is indicated for the treatment of adult patients with who functional class (fc) ii to iii withinoperable cteph,persistent or recurrent cteph after surgical treatment,to improve exercise capacity. pulmonary arterial hypertension (pah)adultsadempas, as monotherapy or in combination with endothelin receptor antagonists, is indicated for the treatment of adult patients with pulmonary arterial hypertension (pah) with who functional class (fc) ii to iii to improve exercise capacity. effekt har visats i ett pah befolkning, inklusive aetiologies av idiopatisk eller ärftlig polycykliska aromatiska kolväten eller pah som associeras med bindvävssjukdom. paediatricsadempas is indicated for the treatment of pah in paediatric patients aged less than 18 years of age and body weight ≥ 50 kg with who functional class (fc) ii to iii in combination with endothelin receptor antagonists.

欧盟 - 瑞典文 - EMA (European Medicines Agency)

canyon pharmaceuticals ltd. - desirudin - venös trombos - antitrombotiska medel - förebyggande av djup venös trombos hos patienter som genomgår elektiv höft- eller knäbytesoperation.

欧盟 - 瑞典文 - EMA (European Medicines Agency)

glaxosmithkline (ireland) limited - ambrisentan - hypertoni, lungformig - antihypertensiva medel, - volibris is indicated for treatment of pulmonary arterial hypertension (pah) in adult patients of who functional class (fc) ii to iii, including use in combination treatment (see section 5.  efficacy has been shown in idiopathic pah (ipah) and in pah associated with connective tissue disease. volibris is indicated for treatment of pah in adolescents and children (aged 8 to less than 18 years) of who functional class (fc) ii to iii including use in combination treatment. efficacy has been shown in ipah, familial, corrected congenital and in pah associated with connective tissue disease (see section 5.

瑞典 - 瑞典文 - Läkemedelsverket (Medical Products Agency)

actavis group ptc ehf. - bosentanmonohydrat - filmdragerad tablett - 125 mg - bosentanmonohydrat 129,082 mg aktiv substans